Links

Tools

Export citation

Search in Google Scholar

Pharmacogenetic analysis of OCTN and DLG5 polymorphisms shows further evidence for association of the OCTN TC risk haplotype with lower response to infliximab in Crohn's disease.

Published in 2005 by Liesbet Henckaerts ORCID, T. Hlavaty, Marc Ferrante, M. Pienk, Marie Joossens, P. Rutgeerts, Séverine Vermeire
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle
Preprint: policy unknown
Upload
Question mark in circle
Postprint: policy unknown
Upload
Question mark in circle
Published version: policy unknown
Upload